1. Home
  2. QMCO vs RNA Comparison

QMCO vs RNA Comparison

Compare QMCO & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quantum Corporation

QMCO

Quantum Corporation

N/A

Current Price

$17.00

Market Cap

129.1M

Sector

Technology

ML Signal

N/A

Logo Avidity Biosciences Inc.

RNA

Avidity Biosciences Inc.

N/A

Current Price

$8.36

Market Cap

141.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
QMCO
RNA
Founded
1980
2025
Country
United States
United States
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
129.1M
141.3M
IPO Year
2025
2025

Fundamental Metrics

Financial Performance
Metric
QMCO
RNA
Price
$17.00
$8.36
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
★ $27.33
$22.00
AVG Volume (30 Days)
★ 1.5M
212.2K
Earning Date
11-09-2026
08-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 64.34
N/A
EPS
N/A
★ N/A
Revenue
★ $372,827,000.00
N/A
Revenue This Year
$20.02
$88.07
Revenue Next Year
$16.01
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 6.65
N/A
52 Week Low
$4.19
$7.49
52 Week High
$35.65
$73.06

Technical Indicators

Market Signals
Indicator
QMCO
RNA
Relative Strength Index (RSI) 41.04 46.75
Support Level $16.74 $7.56
Resistance Level $18.48 $8.50
Average True Range (ATR) 1.70 0.36
MACD -0.25 0.12
Stochastic Oscillator 51.18 47.93

Price Performance

Historical Comparison
QMCO
RNA

About QMCO Quantum Corporation

Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data in the era of artificial intelligence (AI). It provides one of the comprehensive and cost-efficient solutions for the entire data lifecycle. The group provides solutions for video, images, audio, and other large files because this unstructured data represents. Its portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The group operates in three geographic regions: Americas, Europe, the Middle East, and Africa (EMEA), and Asia Pacific (APAC).

About RNA Avidity Biosciences Inc.

Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.

Share on Social Networks: